Drug archive
Pegvisomant (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Growth hormone suppressant, acromegaly
Description
Pegvisomant ((peg VI soe mant)) is used to treat a condition called acromegaly, which is caused by too much growth hormone in the body. Too much growth hormone produced in adults causes the hands, feet, and parts of the face to become large, thick, and bulky. Other problems such as arthritis also can develop. Pegvisomant works by binding to the growth hormone receptor and preventing the actions of too much growth hormone.
This medicine is available only with your doctor's prescription, in the following dosage forms:
- Injection (US)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Somavert
† Not commercially available in Canada.